Skip to main content
Fig. 2 | Cardio-Oncology

Fig. 2

From: Cardiac and noncardiac biomarkers in patients undergoing anthracycline chemotherapy – a prospective analysis

Fig. 2

Changes in noncardiac biomarker levels at Pre-Chemo, End-Chemo, and Post-Chemo. (a) activated caspase-1 (CASP-1), (b) activated caspase-3 (CASP-3), (c) tumor necrosis factor-α (TNF-α), (d) galectin-3 (Gal3), (e) myeloperoxidase (MPO), (f) 8-hydroxy-2'-deoxyguanosine (OHDG), (g) C-reactive protein (CRP) biomarker levels at three time points: prior to chemotherapy (Pre-Chemo), after the last dose of doxorubicin (End-Chemo), and 3-6 months after completion of doxorubicin (Post-Chemo). *** p < 0.001, ** p < 0.01, * p < 0.05

Back to article page

Cardio-Oncology

ISSN: 2057-3804

Contact us